{"id":"https://openalex.org/W32727537","doi":null,"title":"[Low-dose oral etoposide and subcutaneous injection of low-dose cytosine arabinoside (Et-A non i.v.) with or without minimum anthracycline for refractory acute non-lymphoblastic leukemia].","display_name":"[Low-dose oral etoposide and subcutaneous injection of low-dose cytosine arabinoside (Et-A non i.v.) with or without minimum anthracycline for refractory acute non-lymphoblastic leukemia].","publication_year":1998,"publication_date":"1998-08-01","ids":{"openalex":"https://openalex.org/W32727537","mag":"32727537","pmid":"https://pubmed.ncbi.nlm.nih.gov/9725056"},"language":"ja","primary_location":{"id":"pmid:9725056","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9725056","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Case Reports"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039523664","display_name":"Machiko Tsukaguchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104391","display_name":"Sakai City Medical Center","ror":"https://ror.org/014nm9q97","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210104391","https://openalex.org/I4405286217"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M Tsukaguchi","raw_affiliation_strings":["Dept. of Internal Medicine, Sakai Municipal Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Internal Medicine, Sakai Municipal Hospital","institution_ids":["https://openalex.org/I4210104391"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Y Furukawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Furukawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5112711436","display_name":"T Kitani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Kitani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00313586,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"10","first_page":"1603","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.010499999858438969,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8830000162124634},{"id":"https://openalex.org/keywords/refractory-leukemia","display_name":"refractory leukemia","score":0.9509999752044678},{"id":"https://openalex.org/keywords/low-dose-cytarabine","display_name":"low-dose cytarabine","score":0.6809999942779541},{"id":"https://openalex.org/keywords/mitoxantrone","display_name":"mitoxantrone","score":0.777999997138977},{"id":"https://openalex.org/keywords/daunorubicin","display_name":"daunorubicin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/vindesine","display_name":"vindesine","score":0.8569999933242798},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.7919999957084656},{"id":"https://openalex.org/keywords/induction-therapy","display_name":"induction therapy","score":0.5960000157356262},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.7929999828338623},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.5929999947547913},{"id":"https://openalex.org/keywords/home-care","display_name":"home care","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.7558711767196655},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7491897344589233},{"id":"https://openalex.org/C2781021840","wikidata":"https://www.wikidata.org/wiki/Q411659","display_name":"Daunorubicin","level":3,"score":0.6391326785087585},{"id":"https://openalex.org/C2779321808","wikidata":"https://www.wikidata.org/wiki/Q416660","display_name":"Vindesine","level":5,"score":0.626996636390686},{"id":"https://openalex.org/C2780847677","wikidata":"https://www.wikidata.org/wiki/Q4674302","display_name":"Aclarubicin","level":4,"score":0.6027265191078186},{"id":"https://openalex.org/C2780923524","wikidata":"https://www.wikidata.org/wiki/Q239426","display_name":"Mitoxantrone","level":3,"score":0.5824353694915771},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.5805037021636963},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.46135637164115906},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.4402086138725281},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.43619656562805176},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4254094064235687},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3784804046154022},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3458417057991028},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3156455457210541},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2902314066886902},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.22214099764823914},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008942","descriptor_name":"Mitoxantrone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014751","descriptor_name":"Vindesine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:9725056","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9725056","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Case Reports"},{"id":"mag:32727537","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9725056","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W77585086","https://openalex.org/W1582471009","https://openalex.org/W1585895556","https://openalex.org/W1882772761","https://openalex.org/W1964891375","https://openalex.org/W1973702005","https://openalex.org/W1979521131","https://openalex.org/W1984574291","https://openalex.org/W1986630370","https://openalex.org/W1997535872","https://openalex.org/W2008945738","https://openalex.org/W2009720434","https://openalex.org/W2011912935","https://openalex.org/W2018189081","https://openalex.org/W2029979788","https://openalex.org/W2038473742","https://openalex.org/W2041882488","https://openalex.org/W2043664938","https://openalex.org/W2049621625","https://openalex.org/W2076848701","https://openalex.org/W2080310417","https://openalex.org/W2081164083","https://openalex.org/W2082698120","https://openalex.org/W2083806615","https://openalex.org/W2087672655","https://openalex.org/W2088544963","https://openalex.org/W2097175728","https://openalex.org/W2104549677","https://openalex.org/W2117022436","https://openalex.org/W2117396697","https://openalex.org/W2117977572","https://openalex.org/W2152061559","https://openalex.org/W2158485828","https://openalex.org/W2158826174","https://openalex.org/W2159249646","https://openalex.org/W2160995259","https://openalex.org/W2161978970","https://openalex.org/W2169674658","https://openalex.org/W2170226759","https://openalex.org/W2179438025","https://openalex.org/W2259938310","https://openalex.org/W2270152626","https://openalex.org/W2307041907","https://openalex.org/W2527824902","https://openalex.org/W2534924637","https://openalex.org/W2564452722","https://openalex.org/W2761275051","https://openalex.org/W2767680469","https://openalex.org/W4300196896","https://openalex.org/W7098463221"],"related_works":["https://openalex.org/W2062599504","https://openalex.org/W2409923935","https://openalex.org/W2064187559","https://openalex.org/W2012245469","https://openalex.org/W2307788069","https://openalex.org/W2027869118","https://openalex.org/W2419178697","https://openalex.org/W2021929491","https://openalex.org/W1503212456","https://openalex.org/W2092208483"],"abstract_inverted_index":{"Low-dose":[0,100],"oral":[1],"etoposide":[2,126],"(50":[3],"mg":[4,77,175,182,190],"for":[5,20,72,128,133,205],"10":[6,129],"to":[7,22,30,58,61,114,170,213],"14":[8,21,73,134],"days)":[9,24],"and":[10,75,131,138,185,203,211],"low-dose":[11,158],"subcutaneous":[12],"injection":[13],"of":[14,64,78,118,176,183,188,191],"cytosine":[15,101],"arabinoside":[16,102],"(15-20":[17],"mg/12":[18],"hours":[19],"17":[23],"(Et-A":[25],"non":[26,68,121,172,198],"i.v.)":[27],"were":[28],"given":[29,71],"refractory":[31],"acute":[32],"non-lymphoblastic":[33],"leukemia":[34],"patients.":[35],"Case":[36,92,142],"1":[37],"was":[38,70,80,94,123,144,160,164,168,178],"a":[39,44,88,95,145],"47-year-old":[40],"woman":[41,97],"who":[42],"had":[43,57],"relapsed":[45],"M0.":[46],"B-DOMP":[47],"therapy":[48,108,159,200,207],"failed":[49],"but":[50,162],"she":[51,139],"recovered":[52],"from":[53,151],"severe":[54],"infection.":[55,156],"She":[56,86,110],"go":[59],"home":[60],"take":[62],"care":[63],"her":[65],"children.":[66],"Et-A":[67,120,171,197],"i.v.":[69,122,199],"days":[74,130,135],"11":[76],"mitoxantrone":[79,184],"added":[81],"on":[82],"the":[83,115],"3rd":[84],"day.":[85],"achieved":[87,140,195],"complete":[89],"remission":[90],"(CR).":[91],"2":[93],"72-year-old":[96],"classified":[98],"M4.":[99],"(Ara-C)":[103],"with":[104,148,155,180,208],"additional":[105],"daunorubicin":[106],"(DNR)":[107],"failed.":[109],"became":[111],"weaker":[112],"due":[113],"gastrointestinal":[116],"toxicity":[117,210],"DNR.":[119],"tried.":[124],"Oral":[125],"(Et)":[127],"Ara-C":[132,157],"proved":[136],"effective,":[137],"CR.":[141,196],"3":[143,189],"59-year-old":[146],"man":[147],"M4":[149],"developed":[150],"myelodysplastic":[152],"syndrome,":[153],"complicated":[154],"begun,":[161],"it":[163],"not":[165],"effective.":[166],"It":[167],"switched":[169],"i.v.,":[173],"40":[174],"DNR":[177],"added,":[179],"12":[181],"double":[186],"administration":[187],"vindesine.":[192],"He":[193],"also":[194],"is":[201],"effective":[202],"available":[204],"induction":[206],"low":[209],"convenient":[212],"daily":[214],"life.":[215]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}